From time to time, the Company is involved in routine litigation that arises in the ordinary course of business.
From time to time, we are involved in routine litigation that arises in the ordinary course of business.
The SSP of hardware is cost plus a reasonable margin.
The awards provide for an aggregate target of 200,709 shares, none of which have been included in the calculation of diluted EPS for the three and nine months ended September 30, 2019 because the related threshold award performance levels have not been achieved as of September 30, 2019.
Our chief operating decision makers ("CODM") utilize three operating segments, "Acute Care EHR," "Post-acute Care EHR" and "TruBridge," based on our three distinct business units with unique market dynamics and opportunities.
The deferred revenue recorded during the nine months ended September 30, 2019 is comprised primarily of the annual renewals of certain software subscriptions billed during the first quarter of each year and deposits collected for future EHR installations.
Additionally, the Company provides financing for purchases of its information and patient care systems to certain healthcare providers under long-term financing arrangements expiring in various years through 2026.Total costs of sales decreased by 2%, or $1.6 million, compared to the first nine months of 2018.
Total costs of sales decreased by 1%, or $0.4 million, compared to the third quarter of 2018.
 TruBridge revenues increased 7%, or $5.0 million, compared to the first nine months of 2018.
 TruBridge revenues increased 11%, or $2.8 million, compared to the third quarter of 2018.
Bad debt expense decreased $0.4 million compared to the first nine months in 2018.
Sales and marketing expenses decreased 7%, or $1.6 million, compared to the first nine months of 2018, primarily due to decreased payroll costs of 11%, or $1.0 million, based on decreased headcount.
The gross margin on these services increased to 49% in the third quarter of 2019 compared to 45% in the third quarter of 2018.
Net cash provided by operating activities increased $10.7 million, from $14.9 million provided by operations for the nine months ended September 30, 2018 to $25.5 million provided by operations for the nine months ended September 30, 2019.
Additionally, the impending 2019 year-end deadline for compliance with the related PI (formerly “Meaningful Use”) program administered by CMS resulted in a $6.6 million decrease in related MU3 installation revenues, which were partially offset by robust sales of other add-on applications that increased $3.7 million compared to the first nine months of 2018.
As a percentage of total revenues, total operating expenses decreased to 45% of revenues in the nine months ended September 30, 2019 compared to 46% in the nine months ended September 30, 2018.Even disclosure controls and procedures determined to be effective can only provide reasonable assurance that their objectives are achieved.Item 1.Legal Proceedings.